THE EFFECT OF EXIT-SITE ANTIBACTERIAL HONEY VERSUS NASAL MUPIROCIN PROPHYLAXIS ON THE MICROBIOLOGY AND OUTCOMES OF PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS AND EXIT-SITE INFECTIONS: A SUB-STUDY OF THE HONEYPOT TRIAL

摘要

Background: The HONEYPOT study recently reported that daily exit-site application of antibacterial honey was not superior to nasal mupirocin prophylaxis for preventing overall peritoneal dialysis (PD)-related infection. This paper reports a secondary outcome analysis of the HONEYPOT study with respect to exit-site infection (ESI) and peritonitis microbiology, infectious hospitalization and technique failure.